🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Neoplasms, Malignant

Prophylactic Inhaled Steroids to Reduce Radiation Pneumonitis Frequency and Severity in Lung Cancer Patients NCT03803787Phase 22 sites📍 Mexico City📍 Mexico City Instituto Nacional de Cancerologia de Mexico · Tests: Inhaled budesonide Medulloblastoma Online Video-based Exercise Pilot Study NCT06898684NA2 sites📍 München📍 Gothenburg Aron Onerup · Tests: Exercise A Study on Adding Precisely Targeted Radiation Therapy (Stereotactic Body Radiation Therapy) to the Usual Treatment Approach (Drug Therapy) in People With Breast Cancer NCT05534438Phase 28 sites📍 Basking Ridge📍 Middletown📍 Montvale Memorial Sloan Kettering Cancer Center · Tests: Stereotactic body radiotherapy Access to Genetic Testing in Underserved Patients With Cancer NCT06422455NA2 sites📍 Los Angeles📍 Rochester University of Southern California · Tests: Best Practice, Educational Intervention, Electronic Health Record Review, Genetic Counseling, Interview GENOCARE: A Prospective, Randomized Clinical Trial of Genotype-Guided Dosing Versus Usual Care NCT05391126NA1 site📍 Lexington Reema A. Patel · Tests: Irinotecan The Level of Patient Participation in Lung and Esophageal Cancer Patients Treated With Definitive Radiochemotherapy. NCT06019455n/a1 site📍 Guangzhou Sun Yat-sen University Ph II Study of Enfortumab Vedotin in Patients With Advanced or Metastatic CRC or HCC NCT06553885Phase 21 site📍 Tampa H. Lee Moffitt Cancer Center and Research Institute · Tests: Enfortumab Vedotin Registry of the German CLL Study Group NCT02863692n/a1 site📍 Dresden German CLL Study Group ELVN-001 for the Treatment of Chronic Myeloid Leukemia With and Without T315I Mutation in Japanese Participants NCT06787144Phase 14 sites📍 Akita📍 Sapporo📍 Suita-shi Enliven Therapeutics · Tests: ELVN-001 Study of Treatment With Intensified Omeprazole Treatment to Prevent High Output Stoma 1 NCT06917963NA2 sites📍 Gdansk📍 Gdynia Medical University of Gdansk · Tests: Intensified intravenous omeprazole therapy (loading dose 80 mg IV, then 40 mg IV twice daily at 6:00 AM and 6:00 PM), S… IMA402 T Cell-Engaging Receptor Molecule (TCER®) in Recurrent and/or Refractory Solid Tumors NCT05958121Phase 1, Phase 229 sites📍 Heidelberg📍 Heidelberg📍 Mannheim Immatics Biotechnologies GmbH · Tests: IMA402, IMA402 and checkpoint inhibitor, IMA402 and chemotherapy, IMA402 and IMA401, IMA402 and monoclonal antibody Safety and Efficacy of Preoperative SBRT and Radical Surgery for Soft Tissue Sarcoma of Extremities NCT06760221NA1 site📍 Hangzhou Second Affiliated Hospital, Zhejiang University, School of … · Tests: stereotactic body raiotherapy AI System for Anatomic Recognition & Lesion Detection in Nasopharyngolaryngoscopy: A Prospective Study NCT07326358n/a1 site📍 Shanghai Ruijin Hospital · Tests: Diagnostic, Diagnostic A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy NCT07188558Phase 336 sites📍 Gilbert📍 Scottsdale📍 Scottsdale Lyell Immunopharma, Inc. · Tests: rondecabtagene autoleucel, axicabtagene ciloleucel, lisocabtagene maraleucel Bolstering Outcomes After Induction With Osimertinib Plus Chemotherapy Through Optimized Site-Directed Primary Tumor Therapy (BOOST Trial) NCT07073365Phase 21 site📍 Busan Pusan National University Hospital · Tests: Local Therapy (Surgery or Radiotherapy) Prospective RegIstration Of the peRformance of the IoTa ADNEX Model in Dutch gYnaecological Practice NCT06103916n/a1 site📍 Veldhoven Maxima Medical Center · Tests: Observational study. Prospective registration of ultrasound data in patients with ovarian tumors for which an ultrasoun… Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles) NCT04427384n/a54 sites📍 Phoenix📍 Little Rock📍 Castro Valley GT Medical Technologies, Inc. · Tests: GammaTile Key Longitudinal Associations With Risk and Glioblastoma Outcomes NCT06625684n/a1 site📍 Durham Duke University Neoadjuvant Radiotherapy Plus Tegafur, Oxaliplatin and Iparomlimab and Tuvonralimab in Resectable Gastric and GE-junction Cancer : A Randomized, Two-arm, Prospective Trial (TRIUNITE-05) NCT07165847Phase 21 site📍 Chongqing Daping Hospital and the Research Institute of Surgery of th… · Tests: Iparomlimab and Tuvonralimab, Oxaliplatin, Tegafur, Radiotherapy Feasibility Assessment of Adapted Physical Activity in Patients Treated for a Brain Tumor NCT07570485NA1 site📍 Rennes Center Eugene Marquis · Tests: adapted physical activity Genetic Determinants of Barrett's Esophagus and Esophageal Adenocarcinoma NCT00288119n/a10 sites📍 Baltimore📍 Rochester📍 St Louis Case Western Reserve University · Tests: Balloon Capsule Device, Endoscopy The Ohio State University (OSU) SCREEN Community Program NCT06666192NA1 site📍 Columbus Ohio State University Comprehensive Cancer Center · Tests: Cancer Screening, Discussion, Educational Activity, Educational Intervention, Focus Group SCRT VS LCRT Followed by PD-L1 Inhibitor Plus CAPEOX as TNT in Patients With LARC NCT07284992Phase 21 site📍 Jinan Shandong Provincial Hospital · Tests: short-term radiotherapy combined with Adebrelimab and capox, long-term radiotherapy combined with Adebrelimab and capox Trilaciclib in Combination With Docetaxel for Second-Line and Beyond Treatment of Locally Advanced or Metastatic NSCLC NCT06929936Phase 21 site📍 Xiamen The First Affiliated Hospital of Xiamen University · Tests: Trilaciclib combined with Docetaxel Identification of Genetic, Phenotypic, Clinical, Biological and Histological Factors Differentiating Patients With Ovarian Cancer Who Are Refractory to Platinum-based Therapy From Patients Defined as Long-term Responders to Platinum-based Therapy NCT07361471NA1 site📍 Clermont-Ferrand Centre Jean Perrin · Tests: molecular analysis A Clinic-wide Intervention (Primary Care-GI Connect) for Improving Rates of Colonoscopy After Abnormal Fecal Immunochemical Test Result in Patients at Federally Qualified Health Centers NCT06568016NA2 sites📍 Los Angeles📍 Los Angeles Jonsson Comprehensive Cancer Center · Tests: Best Practice, Communication Intervention, Communication Intervention, Coordination, Educational Intervention Tagraxofusp and Azacitidine With Venetoclax in Newly Diagnosed Secondary AML After Hypomethylating Agents NCT05442216Phase 27 sites📍 Miami📍 Orlando📍 Buffalo Joshua Zeidner · Tests: Tagraxofusp, Azacitidine, Venetoclax Iparomlimab and Tuvonralimab as Neoadjuvant Therapy for Resectable Hepatocellular Carcinoma With High Risk of Recurrence NCT06954116Phase 21 site📍 Wuhan Tongji Hospital · Tests: Iparomlimab and Tuvonralimab (QL1706), Partial hepatectomy GETNE Registration of Thyroid Cancer NCT03765333n/a1 site📍 Barcelona Grupo Espanol de Tumores Neuroendocrinos Tirelizumab in Combination With Carboplatin and Albumin-binding Paclitaxel for Neoadjuvant Therapy in HNSCC NCT05941338Phase 21 site📍 Guangzhou Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University · Tests: Tirelizumab ,+Carboplatin+albumin-bound paclitaxel
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy